Application of rectus abdominis sheath or transverse abdominis plane nerve block combined with dexmedetomidine and esketamine in anesthesia for gastrointestinal surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051109

Enrollment

Unknown

Registered

2021-09-13

Start date

2021-09-20

Completion date

Unknown

Last updated

2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Surgery Disease

Interventions

Group 3:Nerve block + intravenous micropump dexmedetomidine

Group 2:Dexmedetomidine intravenous micropump

Group 1:Ultrasound-guided rectus sheath or transversus abdominis plane nerve block

Control group:Sufentanil

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 35-70 years, ASA class I-III, patients who are going to undergo gastrointestinal surgery.

Exclusion criteria

Exclusion criteria: 1. Those with insufficiency of important organs. 2. Patients with mental and psychological problems. 3. Patients with severe sinus bradycardia or type II block.

Design outcomes

Primary

Measure	Time frame
Heart rate;Systolic blood pressure;Diastolic blood pressure;	—

Countries

China

Contacts

Public ContactWang Juntao

The Affiliated Hospital of Qingdao University

wangjuntao1228@163.com+86 532 82911083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026